Literature DB >> 30515557

Prognostic subdivision of pT2 rectal carcinomas.

Susanne Merkel1, Klaus Weber2, Maximilian Brunner2, Justus Baecker2, Abbas Agaimy3, Jonas Göhl2, Werner Hohenberger2, Vera Schellerer2, Robert Grützmann2.   

Abstract

PURPOSE: The aim of the present study is to explore the prognostic impact of a subdivision of pT2 by the depth of invasion into the muscularis propria in rectal carcinomas.
METHODS: Data from 269 consecutive patients with rectal carcinoma treated with primary tumor resection and lymph node dissection between 1986 and 2012 were analyzed with respect to locoregional and distant recurrence, disease-free survival, and overall survival. The depth of invasion into the muscularis propria of pT2 carcinomas was categorized by the pathologist into two groups: pT2a, invasion into the inner half of the muscularis propria; pT2b, invasion into the outer half of the muscularis propria.
RESULTS: One hundred nineteen of the 269 patients (44.2%) were classified pT2a and 150 patients (55.8%) were classified pT2b. In univariate analysis, significant differences between pT2a and pT2b carcinomas were found for locoregional recurrences (5-year rates 5.3 vs 14.0%; p = 0.025), distant metastases (14.1 vs 18.7%; p = 0.026), disease-free survival (78.2 vs 62.5%; p = 0.022), and overall survival (87.4 vs 72.5%; p = 0.013). In multivariate Cox regression analysis, the pT2 subdivision was found to be an independent risk factor for locoregional recurrence (hazard ratio 2.6; p = 0.023), disease-free survival (HR 1.4; p = 0.022), and overall survival (HR 1.5; p = 0.020), but only marginally for distant metastasis (HR 1.7; p = 0.083). Other independent prognostic factors were lymph node status, lymphatic invasion, and grading.
CONCLUSIONS: The depth of invasion into the muscularis propria is an independent prognostic factor for pT2 rectal carcinomas that will support decision-making for preoperative, surgical, and postoperative treatment.

Entities:  

Keywords:  Prognosis; Prognostic factor; Rectal carcinoma; pT2; pT2 subdivision

Mesh:

Year:  2018        PMID: 30515557     DOI: 10.1007/s00384-018-3216-2

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  10 in total

1.  Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis.

Authors:  Eisar Al-Sukhni; Laurent Milot; Mark Fruitman; Joseph Beyene; J Charles Victor; Selina Schmocker; Gina Brown; Robin McLeod; Erin Kennedy
Journal:  Ann Surg Oncol       Date:  2012-01-20       Impact factor: 5.344

2.  The prognostic inhomogeneity in pT3 rectal carcinomas.

Authors:  S Merkel; U Mansmann; M Siassi; T Papadopoulos; W Hohenberger; P Hermanek
Journal:  Int J Colorectal Dis       Date:  2001-09       Impact factor: 2.571

3.  Long-term outcomes and quality of life after rectal carcinoma surgery.

Authors:  C Hoerske; K Weber; J Goehl; W Hohenberger; S Merkel
Journal:  Br J Surg       Date:  2010-08       Impact factor: 6.939

4.  The influence of abdomino-peranal (intersphincteric) resection of lower third rectal carcinoma on the rates of sphincter preservation and locoregional recurrence.

Authors:  W Hohenberger; S Merkel; K Matzel; B Bittorf; T Papadopoulos; J Göhl
Journal:  Colorectal Dis       Date:  2006-01       Impact factor: 3.788

5.  Prognostic subdivision of ypT3 rectal tumours according to extension beyond the muscularis propria.

Authors:  S Merkel; K Weber; V Schellerer; J Göhl; R Fietkau; A Agaimy; W Hohenberger; P Hermanek
Journal:  Br J Surg       Date:  2014-01-29       Impact factor: 6.939

6.  Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer.

Authors:  K J Emmertsen; S Laurberg
Journal:  Br J Surg       Date:  2013-09       Impact factor: 6.939

7.  The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?

Authors:  R J Heald; E M Husband; R D Ryall
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

8.  Sexual Function and Health-Related Quality of Life in Long-Term Rectal Cancer Survivors.

Authors:  Virginia Sun; Marcia Grant; Christopher S Wendel; Carmit K McMullen; Joanna E Bulkley; Lisa J Herrinton; Mark C Hornbrook; Robert S Krouse
Journal:  J Sex Med       Date:  2016-07       Impact factor: 3.802

9.  Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study.

Authors:  Fiona G M Taylor; Philip Quirke; Richard J Heald; Brendan J Moran; Lennart Blomqvist; Ian R Swift; David Sebag-Montefiore; Paris Tekkis; Gina Brown
Journal:  J Clin Oncol       Date:  2013-11-25       Impact factor: 44.544

10.  Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial.

Authors:  R Ruppert; T Junginger; H Ptok; J Strassburg; C A Maurer; P Brosi; J Sauer; J Baral; M Kreis; D Wollschlaeger; P Hermanek; S Merkel
Journal:  Br J Surg       Date:  2018-05-09       Impact factor: 6.939

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.